DavidElihuGreenbergMD
Infectious Disease • Dallas, TXHealthcare Associated Infections, Transplant/Immunocompromised States
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Greenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Stop 9113
Dallas, TX 75390Phone+1 214-648-6485Fax+1 214-645-9485
Summary
- Dr. David Greenberg is an infectious disease specialist in Dallas, TX and is affiliated with multiple hospitals in the area, including University of Texas Southwestern Medical Center and UT Southwestern Zale Lipshy Hospital. He received his medical degree from Baylor College of Medicine and has been in practice 18 years. He specializes in healthcare associated infections and transplant/immunocompromised states.
Education & Training
National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2003 - 2007
Baylor College of MedicineResidency, Internal Medicine, 1999 - 2003- Baylor College of MedicineClass of 1999
Certifications & Licensure
TX State Medical License 2002 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Alternating magnetic fields (AMF) and linezolid reduce Staphylococcus aureus biofilm in a large animal implant model.Isuru A Somawardana, Bibin Prasad, Walker Kay, Connor Hunt, Jacob Adams
The Journal of Infection. 2024-11-01 - 2 citationsIntermittent alternating magnetic fields diminish metal-associated biofilm in vivo.Sumbul Shaikh, Norman A Lapin, Bibin Prasad, Carolyn R Sturge, Christine Pybus
Scientific Reports. 2023-12-17 - 1 citationsactivity of cefiderocol againstisolated from cystic fibrosis patients.Marguerite L Monogue, Dhara Desai, Christine A Pybus, James M Sanders, Andrew E Clark
Microbiology Spectrum. 2023-12-12
Press Mentions
New Drug Candidate May Be Effective Against 300 Drug-Resistant BacteriaAugust 10th, 2022
DFW Medical Device Startup Eyes New Funding as It Looks Toward Human TrialsMarch 23rd, 2021- Tracing Coronavirus VariantsJanuary 29th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
